Pages that link to "Q42019558"
Jump to navigation
Jump to search
The following pages link to Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall (Q42019558):
Displaying 50 items.
- The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis (Q21328672) (← links)
- APOE genotype and stress response - a mini review (Q26741633) (← links)
- HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders (Q27691344) (← links)
- Apolipoprotein E isoforms and lipoprotein metabolism (Q28249988) (← links)
- Mouse models of atherosclerosis: a historical perspective and recent advances. (Q30238973) (← links)
- A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions (Q30402554) (← links)
- Genetics and functional imaging: effects of APOE, BDNF, COMT, and KIBRA in aging (Q30890481) (← links)
- Transcriptome of the GSH-Depleted Lens Reveals Changes in Detoxification and EMT Signaling Genes, Transport Systems, and Lipid Homeostasis (Q33727606) (← links)
- Mechanisms that regulate macrophage burden in atherosclerosis (Q33761114) (← links)
- Patients with type 1 diabetes show signs of vascular dysfunction in response to multiple high-fat meals (Q33792579) (← links)
- Influence of domain stability on the properties of human apolipoprotein E3 and E4 and mouse apolipoprotein E. (Q33807188) (← links)
- Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features (Q33813945) (← links)
- apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL. (Q33825134) (← links)
- Swapping the N- and C-terminal domains of human apolipoprotein E3 and AI reveals insights into their structure/activity relationship (Q33828806) (← links)
- Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease (Q33885504) (← links)
- Human plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein E polymorphism (Q33933106) (← links)
- The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis (Q33960847) (← links)
- In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-β pathology (Q33995580) (← links)
- Agile delivery of protein therapeutics to CNS (Q34079647) (← links)
- Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review (Q34238630) (← links)
- Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation (Q35014212) (← links)
- Global liver gene expression differences in Nelore steers with divergent residual feed intake phenotypes (Q35238125) (← links)
- High density lipoprotein structure-function and role in reverse cholesterol transport (Q35547011) (← links)
- The Association Between Apolipoprotein E and Functional Outcome After Traumatic Brain Injury: A Meta-Analysis (Q35844835) (← links)
- Animal models of atherosclerosis (Q35903298) (← links)
- Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress (Q36201919) (← links)
- Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice (Q36260399) (← links)
- The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet. (Q36329123) (← links)
- Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy (Q36462050) (← links)
- Allele-dependent thermodynamic and structural perturbations in ApoE variants associated with the correction of dyslipidemia and formation of spherical ApoE-containing HDL particles. (Q36536427) (← links)
- Apolipoprotein E2 accentuates postprandial inflammation and diet-induced obesity to promote hyperinsulinemia in mice (Q36560499) (← links)
- Effect of SORT1, APOB and APOE polymorphisms on LDL-C and coronary heart disease in Pakistani subjects and their comparison with Northwick Park Heart Study II. (Q36836880) (← links)
- ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis (Q36843340) (← links)
- Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels. (Q36865222) (← links)
- ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells (Q37186078) (← links)
- Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence (Q38407177) (← links)
- The effect of host genetics on the gut microbiome (Q38441242) (← links)
- Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights (Q38543425) (← links)
- Role of Syndecans in Lipid Metabolism and Human Diseases (Q38543429) (← links)
- Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux. (Q38747495) (← links)
- Low-Density Lipoprotein Receptor-Related Proteins in Skeletal Development and Disease (Q39374128) (← links)
- Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact. (Q39380623) (← links)
- Dissociation of Apolipoprotein E Oligomers to Monomer Is Required for High-Affinity Binding to Phospholipid Vesicles (Q41973817) (← links)
- Fluorescence analysis of the lipid binding-induced conformational change of apolipoprotein E4. (Q42005396) (← links)
- Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. (Q42173611) (← links)
- Fluorescence study of domain structure and lipid interaction of human apolipoproteins E3 and E4. (Q42174067) (← links)
- Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses (Q42655692) (← links)
- Hepatic and Aortic Arch Expression and Serum Levels of Syndecan-1 in ApoE-/- Mice (Q45158054) (← links)
- Apolipoprotein E3-mediated cellular uptake of reconstituted high-density lipoprotein bearing core 3, 10, or 17 nm hydrophobic gold nanoparticles. (Q46024070) (← links)
- Proteomic Profiling of Liver and Plasma in Chronic Ethanol Feeding Model of Hepatic Alcohol Dehydrogenase-Deficient Deer Mice (Q46894054) (← links)